Abstract
Introduction
Obesity and ADHD have become increasingly common diagnoses. In the last decade, research has found that there is a high prevalence of obesity in patients with ADHD. The mainstays of management in the general population include lifestyle modifications, pharmacotherapies, and/or bariatric surgery. However, there is a lack of understanding of appropriate management of patients with both ADHD and obesity.
Methods
We identified those with obesity for at least five consecutive years (BMI > 30) in the TriNetX database before separating into two groups based on the presence or absence of ADHD. We assessed both the distribution of treatment modalities and the change in average BMI over time in each of our four groups across 5 years.
Results
Average BMI decreased over time in all groups, with the smallest change seen in the ADHD Pharmacology cohort (− 0.366 kg/m2) and the largest in the ADHD Surgery group (− 8.532 kg/m2). Average BMIs at the 5-year mark were significantly different.
Conclusion
Our research found that pharmacological management of individuals with ADHD was only half as effective for individuals with ADHD than our control. Though surgical management of patients with ADHD is roughly 20 times more effective in managing obesity, it was not used as frequently in comparison to medication for management of weight.
Graphical Abstract
Similar content being viewed by others
Data Availability
The original data presented in the study are included in the article, further inquiries can be directed to the corresponding author. The data that support the findings of this study are available from TriNetX. Restrictions apply to the availability of these data, which were used under license for this study. Data are available from https://trinetx.com/with the permission of TriNetX.
References
NHANES. Adult obesity facts CDC 2021. https://www.cdc.gov/obesity/data/adult.html. Accessed 2023.
Center for Disease Control and Prevention. Prevalence of childhood obesity in the United States. CDC, 17 05 2022. https://www.cdc.gov/obesity/data/childhood.html. Accessed 24 01 2023.
Body Mass Index: Considerations for Practitioners Centers for Disease Control and Prevention. Body mass index: considerations for practitioners. https://www.cdc.gov/obesity/downloads/bmiforpactitioners.pdf. Accessed 08 Sept 2023
Heffron SP, Parham JS, Pendse J, et al. Treatment of obesity in mitigating metabolic risk. Circ Res. 2020;126(11):1646–65.
Provost DA, Malhotra S. Indications and contraindications for bariatric surgery, in The ASMBBS Textbook of Bariatric Surgery. Bariatric Surgery. 2015;1:73-76.
ASMBS. Who is a candidate for bariatric surgery?. https://asmbs.org/patients/who-is-a-candidate-for-bariatric-surgery. Accessed 2023.
Hampl SE, Hassink SG, Skinner AC et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Am Acad Pediatr. 2023.
O’brien P, Hindle A, Brennan L. long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 200year outcomes after adjustable gastric banding,” Obes Surg. 2019;29:3-14.
Xia Q, Julie AC, Ahmad H, Si L et al. Bariatric surgery is a cost-saving treatment for obesity - a comprehensive meta-analysis and updated systemic review of health economic evluations of bariatric surgery. Obes Rev. 2020;21(1).
Chen M, Pan T, Hsu J et al. Risk of type 2 diabetes in adolescents and young adults with attention-deficit/hyperactivity disorder: a nationwide longitudinal study. J Clin Psychiatry, 2018;79(3).
Williams A, Giust J, Kronenberger W, et al. Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges. Neuropsychiatr Dis Treat. 2016;12:287–96.
Gao M, Koupil I, Sjoqvist H, et al. Psychiatric comorbidity among women with endometriosis: nationwide cohort study in Sweden. Am J Obstet Gynecol. 2020;223(3):415.e1-415.e16.
National Center on Birth Defects and Developmental Disabilities. Attention deficit / hyperactivity disorder. https://www.cdc.gov/ncbddd/adhd/data.html. Accessed 08 Sept 2022
Rabbitts J, Groenewald C. Epidemiology of pediatric surgery in the United States. Pediatr Anesthesiol. 2020;1083-1090.
Welbourn R, Hollyman M, Kinsman R, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg. 2019;29:782–95.
Mohapatra S, Gangadharan K, Pitchumoni CS. Malnutrition in obesity before and after bariatric surgery. Disease-a-Month. 2020.
Stenberg E, Larsson H, Marsk R, et al. Association between attention deficit hyperactivity disorder and outcomes after metabolic and bariatric surgery: a nationwide propensity-matched cohort study. Surg Obes Relat Dis : Off J Am Soc Bariatric Surg. 2023;19(2):92–100.
Mocanu V, Tavakoli I, MacDonald A, et al. The impact of ADHD on outcomes following bariatric surgery: a systematic review and meta-analysis. Obes Surg. 2019;29(4):1403–9.
Cortese S. The association between ADHD and obesity: intriguing, progressively more investigated, but still puzzling. Brain Scientific. 2019;9(10):256.
Raziel A, Sakran N, Goitein D. The relationship between attention deficit hyperactivity disorders (ADHD) and obesity. Harefuah. 2014;153(9):541–55.
Quesada D, Ahmed NU, Fennie KP, et al. A review: associations between attention-deficit/hyperactivity disorder, physical activity, medication use, eating behaviors and obesity in children and adolescents. Arch Psychiatr Nurs. 2018;32(3):495–504.
Davis C. Attention-deficit/hyperactivity disorder: associations with overeating and obesity. Current Psychiatry Rep. 2019;12(5):389–95.
Lange K, Reichl S, Lange K, et al. The history of attention deficit hyperactivity disorder. Attent Deficit Hyperactive DIsorder. 2010;2(4):241–55.
El AMine F, Heidinger B, Camerone JD et al. Two-month administration of methylphenidate improves olfactory sensitivity and suppresses appetite in individuals with obesity. Can J Physiol Pharmacol 2022;100(5):432-440.
S. Evis, A. Cobian, H. Truong et al “Implications of multiple complications on the postoperative recovery of general surgery patients,” Annual Surgery 2016:1213-1218.
Hale E, Kennis M, Yoojin Y. Post-operative complications and ADHD. Child Adolescent Psychiatry: Autism and Other Neurodevelopmental Dis. 2022.
TriNetX. Publication guidelines, TriNetX. https://trinetx.com/real-world-resources/publications/trinetx-publication-guidelines/. Accessed 11 July 2022.
Djalalinia S, Qorbani M, Peykari N, et al. Health impacts of obesity. Pak J Med Sci. 2015;31(1):239–42.
ASMBS. ASMBS endorsed procedures and FDA approved devices. 11 May 2022. https://asmbs.org/resources/endorsed-procedures-and-devices. Accessed 01 Sep 2023.
Cortese S, Angriman M, Maffeis C, et al. Attention deficit/hyperactivity disorder (ADHD) and obestiy: a systemic review of the literature. Crit Rev Food Sci Nutr. 2008;48(6):524–37.
Gadde KM, Parker CB, Maner LG, Wagner HR. et al. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women. Obes Res, 2001;9(9):544-551.
Wim V, Geertruida BE, Wim VdN K. Cornealis K. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2017;10
Caroline MA, Louis JA, Daniel BH et al. Pharmacological management of obesity guideline resources. JCEM, 2016.
Klaus L. Diet, exercise, and mental disorders - public health challenges of the future. Mov Nutr Health Dis. 2018;2:39–59.
Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD. Postgrad Med. 2010;122(1):184–91.
Yanovski S, Yanovski J. Long-term drug treatment for obesity: a systemic and clinical review. JAMA. 2014;311(1):74–86.
Premkumar A, Samaan JS, Samakar K. Factors associated with bariatric surgery referral patterns: a systemic review. J Surg Res. 2022;276:54–75.
Li YJ, Xie XN, Lei X et al. Global prevalence of obesity, overweight, and underweight in children, adolescents, and adults with autism spectrum disorder, attention-deficit hyperactivity disorder: a systemic review and metanalysis. Obes Rev. 2020;21(21).
Dixon JB. The effect of obesity on health outcomes. Mol Cell Endocrinol. 2010;316(2):104–8.
Nigg JT. Attention-deficit/hyperactivity disorder and adverse health outcomes. Clin Psychol Rev. 2013;316(2):215–28.
Hegvik T, Instanes J, Haavik J, et al. Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study. Eur Child Adolesc Psychiatry. 2018;5(27):663–75.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
This article does not contain any studies with human participants or animals performed by any of the authors. For this type of study, formal consent is not required.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
• Obesity and ADHD have become increasingly prevalent in the last few decades.
• Pharmacotherapies for obesity are only half as effective for individuals with ADHD than for individuals without ADHD in helping them lose weight.
• Patients with both ADHD and obesity who underwent surgery lost over 20 times more weight compared to the ADHD Pharmacology group; however, surgery is used only a ninth as often as medication.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Dickinson, K., Parmar, P., Reyes, A.B. et al. Bariatric Surgery Is Highly Effective and Underutilized in Patients with ADHD: A 5-Year Retrospective Cohort Study. OBES SURG (2024). https://doi.org/10.1007/s11695-024-07211-7
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11695-024-07211-7